Patient Square Capital’s EyePoint Inc EYPT Stock Holding History

Patient Square Capital’s Portfolio EYPT Stock Details EYPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.3M	Sell	720,000 -75,000	-9%	-$1M	1.6%	18
2026 Q1	$10.2M	Buy	795,000 +15,000	+2%	+$224K	1.82%	15
2025 Q4	$14.3M	Sell	780,000 -231,839	-23%	-$3.29M	3.05%	8
2025 Q3	$14.4M	Sell	1,011,839 -340,998	-25%	-$3.93M	3.85%	3
2025 Q2	$12.7M	Sell	1,352,837 -129,140	-9%	-$892K	4.59%	4
2025 Q1	$8.03M	Buy	1,481,977 +71,646	+5%	+$501K	3.32%	4
2024 Q4	$10.5M	Buy	1,410,331 +48,352	+4%	+$450K	3.93%	5
2024 Q3	$10.9M	Buy	+1,361,979	New	+$12M	4.04%	5

Other funds holding EYPT

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Patient Square Capital's EYPT Position: Q2 2026 in Review

Patient Square Capital reduced its EyePoint Inc (EYPT) stake by 9.4% in Q2 2026, selling an estimated $1M and leaving 720,000 shares worth $10.3M. The position accounts for 1.6% of the portfolio, ranked #18.

Patient Square Capital first reported a position in EYPT in Q3 2024 and has held it in 8 quarters since. The position peaked at $14.4M in Q3 2025. 188 funds tracked by Wall St. Rank hold EYPT as of Q2 2026.

Patient Square Capital held 720,000 shares of EyePoint Inc worth $10.3M as of Q2 2026.
Patient Square Capital sold 75,000 EyePoint Inc shares in Q2 2026, an estimated $1M.
EyePoint Inc made up 1.6% of Patient Square Capital's portfolio in Q2 2026, its #18 holding.
Patient Square Capital first reported a position in EyePoint Inc in Q3 2024 and has held it in 8 quarters since.
Patient Square Capital's EyePoint Inc position peaked at $14.4M in Q3 2025.
188 funds tracked by Wall St. Rank held EyePoint Inc as of Q2 2026.

Based on Patient Square Capital's 13F filing for Q2 2026, filed 12 Aug 2026.